Literature DB >> 30555738

The regulatory network of nasopharyngeal carcinoma metastasis with a focus on EBV, lncRNAs and miRNAs.

Chen-Xuan Zhao1,2, Wei Zhu1,2, Zheng-Qing Ba1,2, Hong-Juan Xu1,2, Wei-Dong Liu1,2, Bin Zhu1,2, Lei Wang1,2, Yu-Jia Song1,2, Shuai Yuan1,2, Cai-Ping Ren1,2.   

Abstract

Metastasis of nasopharyngeal carcinoma (NPC) remains a main cause of death for NPC patients even though great advances have been made in therapeutic approaches. An in-depth study into the molecular mechanisms of NPC metastasis will help us combat NPC. Epstein-Barr virus (EBV) infection is an evident feature of nonkeratinizing NPC and is strongly associated with tumor metastasis. Recently, long noncoding RNAs (lncRNAs) and microRNAs (miRNAs) have become a hot topic of research due to their epigenetic regulatory roles in NPC metastasis. The EBV products, lncRNAs and miRNAs can target each other and share several common signaling pathways, which form an interconnected, complex molecular regulatory network. In this review, we discuss the features of this regulatory network and summarize the molecular mechanisms of NPC metastasis, focusing on EBV, lncRNAs and miRNAs with updated knowledge.

Entities:  

Keywords:  EBV; Nasopharyngeal carcinoma; lncRNA; metastasis; miRNA; regulation

Year:  2018        PMID: 30555738      PMCID: PMC6291648     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  13 in total

1.  PRDX1 is a Tumor Suppressor for Nasopharyngeal Carcinoma by Inhibiting PI3K/AKT/TRAF1 Signaling.

Authors:  Hongmei Xiao; Taoyu Yang; Lingli Yan; Jihong Feng; Boyan Huang; Yu Jiang
Journal:  Onco Targets Ther       Date:  2020-09-15       Impact factor: 4.147

2.  Novel long non-coding RNA lncAMPC downregulates PTEN via miR-214 to promote nasopharyngeal carcinoma progression.

Authors:  Xianqing Li; Shunlin Ouyang
Journal:  Mol Cell Biochem       Date:  2022-01-21       Impact factor: 3.396

3.  Circular RNA Hsa_circ_0066755 as an Oncogene via sponging miR-651 and as a Promising Diagnostic Biomarker for Nasopharyngeal Carcinoma.

Authors:  Jian Wang; Jinyu Kong; Zhong Nie; Diansen Chen; Jun Qiang; Wanqin Gao; Xiaojie Chen
Journal:  Int J Med Sci       Date:  2020-06-15       Impact factor: 3.738

4.  Knockdown of EBV-encoded circRNA circRPMS1 suppresses nasopharyngeal carcinoma cell proliferation and metastasis through sponging multiple miRNAs.

Authors:  Qianwen Liu; Mingxia Shuai; Yong Xia
Journal:  Cancer Manag Res       Date:  2019-08-27       Impact factor: 3.989

5.  Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway.

Authors:  Yiyi Liu; Qingping Jiang; Xiong Liu; Xian Lin; ZiBo Tang; Chen Liu; Jin Zhou; Mengyang Zhao; Xin Li; Zhao Cheng; Libo Li; Yingying Xie; Zhen Liu; Weiyi Fang
Journal:  EBioMedicine       Date:  2019-10-05       Impact factor: 8.143

6.  Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review).

Authors:  Shan-Qiang Zhang; Su-Ming Pan; Si-Xian Liang; Yu-Shuai Han; Hai-Bin Chen; Ji-Cheng Li
Journal:  Int J Oncol       Date:  2021-03-02       Impact factor: 5.650

7.  Long noncoding RNA SLC9A3‑AS1 increases E2F6 expression by sponging microRNA‑486‑5p and thus facilitates the oncogenesis of nasopharyngeal carcinoma.

Authors:  Jiansheng Li; Dongzhi Li; Xianhua Zhang; Cuijuan Li; Fengjuan Zhu
Journal:  Oncol Rep       Date:  2021-06-24       Impact factor: 3.906

Review 8.  Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma.

Authors:  Yuanbo Kang; Weihan He; Caiping Ren; Jincheng Qiao; Qiuyong Guo; Jingyu Hu; Hongjuan Xu; Xingjun Jiang; Lei Wang
Journal:  Signal Transduct Target Ther       Date:  2020-10-23

9.  An Integrated Analysis of mRNAs and miRNAs Microarray Profiles to Screen miRNA Signatures Involved in Nasopharyngeal Carcinoma.

Authors:  Lei Liu; Hailing Wang; Chaohui Yan; Shudong Tao
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

10.  FBXL19‑AS1 promotes the progression of nasopharyngeal carcinoma by acting as a competing endogenous RNA to sponge miR‑431 and upregulate PBOV1.

Authors:  Hongjun Dong; Chao Huang; Jingjing Huang
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.